Zobrazeno 1 - 10 of 55 pro vyhledávání: '"Jason J. Cheng"'
1
The neuropathology of intracerebroventriculart-butylhydroperoxide
Autor: Jason J. Cheng, James D. Adams, Mike Nguyen, Yue-Ming Huang, Lori K. Klaidman, Beat Knusel, Aileen M. Kuda, Zhi-Jun Wang
Publikováno v: Molecular and Chemical Neuropathology. 22:123-142
t-Butylhydroperoxide can be used as a model oxidative stress-inducing agent in the brain following intracerebroventricular administration. Mice were treated with saline, t-butanol, or t-butylhydroperoxide. t-Butanol is the major metabolite of t-butyl
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cbf738d9a3cf2492a29c8517706008d
https://doi.org/10.1007/bf03160100
Zobrazit plný text záznamu
2
Functions of the C-terminal domain of varicella-zoster virus glycoprotein E in viral replication in vitro and skin and T-cell tropism in vivo
Autor: Ann M. Arvin, Jason J. Cheng, Jennifer F. Moffat, Leigh Zerboni, Chengjun Mo, Marvin Sommer, Shaye Stamatis
Publikováno v: Journal of virology. 78(22)
Varicella-zoster virus (VZV) glycoprotein E (gE) is essential for VZV replication. To further analyze the functions of gE in VZV replication, a full deletion and point mutations were made in the 62-amino-acid (aa) C-terminal domain. Targeted mutation
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08230b4a59ebf0ef3f4320133698046f
https://pubmed.ncbi.nlm.nih.gov/15507627
Zobrazit plný text záznamu
3
Direct identification of ventrointermediate nucleus of the thalamus on magnetic resonance and computed tomography images
Autor: Francis J. Hahn, Arun Angelo Patil, Thomas Falloon, Stephanie Wang, Jason J. Cheng
Publikováno v: Surgical neurology. 51(6)
OBJECTIVE The ventro-intermediate (Vim) nucleus of the thalamus is a commonly used target for the treatment of tremor. The thalamic fasciculus contains myelinated fibers, believed to play a role in the generation of tremor, that converge into a dense
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8381bac7478e0dab335d767dc3cd585
https://pubmed.ncbi.nlm.nih.gov/10369238
Zobrazit plný text záznamu
5
Mutation of a gene encoding a protein with extracellular matrix motifs in Usher syndrome type IIa
Autor: Su Fang Yao, Cynthia C. Morton, Marta L. Tamayo, Denise Yan, William J. Kimberling, Kirk W. Beisel, James D. Eudy, Heidi L. Rehm, Jason J. Cheng, Denise M. Hoover, Iqbal Ahmad, Michael D. Weston, Carmen Ayuso, Cor W. R. J. Cremers, Janos Sumegi, Claes Möller, Catherine B. Talmadge, Anand Swaroop, S. Davenport, Manling Ma-Edmonds
Publikováno v: Science, 280, pp. 1753-1757
Science, 280, 1753-1757
Usher syndrome type IIa (OMIM 276901), an autosomal recessive disorder characterized by moderate to severe sensorineural hearing loss and progressive retinitis pigmentosa, maps to the long arm of human chromosome 1q41 between markers AFM268ZD1 and AF
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e2ffbd4aabb63029df34bc996506941
https://pubmed.ncbi.nlm.nih.gov/9624053
Zobrazit plný text záznamu
6
Akademický článek
Safety amid the scalpels: creating psychological safety in the operating room.
Autor: Cohen JB; Moffitt Cancer Center, Tampa, Florida., Feldman-Brillembourg JA; Sibley Memorial Hospital & Howard University Hospital, Washington, District of Columbia., Cheng J; Kaiser Permanente, National Safety Director-The Permanente Federation, Pasadena, California., Rangrass G; SSM Health Saint Louis University Hospital, Saint Louis, Missouri, USA.
Publikováno v: Current opinion in anaesthesiology [Curr Opin Anaesthesiol] 2024 Dec 01; Vol. 37 (6), pp. 669-675. Date of Electronic Publication: 2024 Sep 04.
Zobrazit plný text záznamu
7
Akademický článek
A Phase 1 Trial of Image Guided Risk Volume-Adapted Postprostatectomy Radiation Therapy.
Autor: Patel KR; Radiation Oncology Branch, National Cancer Institute, National Institutes fo Health, Bethesda, Maryland., Mena E; Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Rowe LS; Department of Oncology, University of Alberta, Edmonton, Alberta, Canada., Ning H; Radiation Oncology Branch, National Cancer Institute, National Institutes fo Health, Bethesda, Maryland., Cheng J; Radiation Oncology Branch, National Cancer Institute, National Institutes fo Health, Bethesda, Maryland., Salerno K; Radiation Oncology Branch, National Cancer Institute, National Institutes fo Health, Bethesda, Maryland., Schott E; Radiation Oncology Branch, National Cancer Institute, National Institutes fo Health, Bethesda, Maryland., Nathan DA; Radiation Oncology Branch, National Cancer Institute, National Institutes fo Health, Bethesda, Maryland., Huang EP; Biometric Research Program, National Cancer Institute, National Institutes of Health, Rockville, Maryland., Lindenberg L; Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Choyke P; Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Turkbey B; Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Citrin DE; Radiation Oncology Branch, National Cancer Institute, National Institutes fo Health, Bethesda, Maryland. Electronic address: citrind@mail.nih.gov.
Publikováno v: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2024 Oct 09. Date of Electronic Publication: 2024 Oct 09.
Zobrazit plný text záznamu
8
Akademický článek
A Phase 1 Trial of Salvage Stereotactic Body Radiation Therapy for Radiorecurrent Prostate Cancer After Brachytherapy.
Autor: Patel KR; Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. Electronic address: Krishnan.Patel@nih.gov., Rydzewski NR; Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Schott E; Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Cooley-Zgela T; Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Ning H; Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Cheng J; Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Salerno K; Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Huang EP; Biometric Research Program, National Cancer Institute, National Institutes of Health, Rockville, Maryland., Lindenberg L; Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Mena E; Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Choyke P; Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Turkbey B; Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Citrin DE; Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Publikováno v: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2024 Aug 01; Vol. 119 (5), pp. 1471-1480. Date of Electronic Publication: 2024 Feb 29.
Zobrazit plný text záznamu
9
Akademický článek
Circulating Tumor DNA Monitoring on Chemo-immunotherapy for Risk Stratification in Advanced Non-Small Cell Lung Cancer.
Autor: Pellini B; Department of Thoracic Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.; Department of Oncologic Sciences, Morsani College of Medicine, University of South Florida, Tampa, Florida., Madison RW; Foundation Medicine, Inc., Cambridge, Massachusetts., Childress MA; Foundation Medicine, Inc., Cambridge, Massachusetts., Miller ST; Foundation Medicine, Inc., Cambridge, Massachusetts., Gjoerup O; Foundation Medicine, Inc., Cambridge, Massachusetts., Cheng J; Genentech, Inc., South San Francisco, California., Huang RSP; Foundation Medicine, Inc., Cambridge, Massachusetts., Krainock M; Natera, Inc., San Carlos, California., Gupta P; Genentech, Inc., South San Francisco, California., Zou W; Genentech, Inc., South San Francisco, California., Shames DS; Genentech, Inc., South San Francisco, California., Moshkevich S; Natera, Inc., San Carlos, California., Ballinger M; Genentech, Inc., South San Francisco, California., Liu MC; Natera, Inc., San Carlos, California., Young A; Foundation Medicine, Inc., Cambridge, Massachusetts., Srivastava MK; Genentech, Inc., South San Francisco, California., Oxnard GR; Foundation Medicine, Inc., Cambridge, Massachusetts., Socinski MA; AdventHealth Cancer Institute, Orlando, Florida.
Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Nov 14; Vol. 29 (22), pp. 4596-4605.
Zobrazit plný text záznamu
10
Akademický článek
A Phase 1 Trial of Focal Salvage Stereotactic Body Radiation Therapy for Radiorecurrent Prostate Cancer.
Autor: Patel KR; Radiation Oncology Branch, National Cancer Institute, National Institutes of Health (NIH), Bethesda, Maryland. Electronic address: Krishnan.Patel@nih.gov., Rydzewski NR; Radiation Oncology Branch, National Cancer Institute, National Institutes of Health (NIH), Bethesda, Maryland., Schott E; Radiation Oncology Branch, National Cancer Institute, National Institutes of Health (NIH), Bethesda, Maryland., Cooley-Zgela T; Radiation Oncology Branch, National Cancer Institute, National Institutes of Health (NIH), Bethesda, Maryland., Ning H; Radiation Oncology Branch, National Cancer Institute, National Institutes of Health (NIH), Bethesda, Maryland., Cheng J; Radiation Oncology Branch, National Cancer Institute, National Institutes of Health (NIH), Bethesda, Maryland., Salerno K; Radiation Oncology Branch, National Cancer Institute, National Institutes of Health (NIH), Bethesda, Maryland., Huang EP; Biometric Research Branch, National Cancer Institute, NIH, Rockville, Maryland., Pinto PA; Urologic Oncology Branch, National Cancer Institute, NIH, Bethesda, Maryland., Lindenberg L; Molecular Imaging Branch, National Cancer Institute, NIH, Bethesda, Maryland., Mena E; Molecular Imaging Branch, National Cancer Institute, NIH, Bethesda, Maryland., Choyke P; Molecular Imaging Branch, National Cancer Institute, NIH, Bethesda, Maryland., Turkbey B; Molecular Imaging Branch, National Cancer Institute, NIH, Bethesda, Maryland., Citrin DE; Radiation Oncology Branch, National Cancer Institute, National Institutes of Health (NIH), Bethesda, Maryland.
Publikováno v: Practical radiation oncology [Pract Radiat Oncol] 2023 Nov-Dec; Vol. 13 (6), pp. 540-550. Date of Electronic Publication: 2023 Jul 11.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje